Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Poland

 

Interview: Dr Peter Byloos, Optegra

As HBI reported last week, UK, Czechia and Poland-based ophthalmology platform Optegra Eye Health Care is being acquired by H2 Equity Partners. HBI caught up with Optegra CEO Dr Peter Byloos to hear his views on the market (and inevitably these days, the impact of COVID), and to find out about Optegra’s plans under new ownership. 

CEE – a land of opportunity?

With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.

Life sells Scanmed after second impairment of 2020

South African hospital group Life Healthcare has sold its Polish subsidiary Scanmed to CEE private equity investor Abris for PLN 340m ($91m) but has had to impair the asset by nearly half as the offer came in below the book value.

Occupational healthcare “cuts cost of absenteeism by half”

The COVID-19 pandemic shifted the working patterns and environments of every type of workforce, resulting in big hits to free-for-service (FFS) business models and new opportunities in remote care. Panellists from Medicover, Medigold and Qualitas discussed this and how good occupational healthcare can reduce the costs of absenteeism by half, at last week's HBI Big Picture Seminar.

Patients starting to avoid care again in Poland

The Polish national payor has recommended that electives be delayed to reduce the risk of COVID-19 infections. HBI hears that after a good summer of business people are again starting to avoid physical care. That could plunge the market back into the dark months of lockdown, which saw one operator considering firing 70% of its staff.

Covid grows the lab market in 2020

HBI Intelligence is now forecasting that most European lab markets will be larger in 2020, than our pre-Covid forecasts. That is despite deep dips in March and April, with some groups thinking about firing two-thirds of their staff and defaulting on rent.

Optegra sales process begins

Multiple sources tell HBI that UK, Czechia and Poland-based ophthalmology platform Optegra is for sale. We take a look at the detailed figures behind the prospective sale, speculate as to price and buyers, and speak to an operator source about his view of the business.

Find Us